Good Steel Used in the Blade: Well-Tailored Type-I Photosensitizers with Aggregation-Induced Emission Characteristics for Precise Nuclear Targeting Photodynamic Therapy.
Good Steel Used in the Blade: Well-Tailored Type-I Photosensitizers with Aggregation-Induced Emission Characteristics for Precise Nuclear Targeting Photodynamic Therapy.
复制标题
刀片用好钢:精心定制的具有聚集诱导发射特性的 I 型光敏剂,用于精确核靶向光动力治疗
DOI:
10.1002/advs.202100524
复制
发表时间:
2021-07
期刊:
影响因子:
--
通讯作者:
Tang BZ
中科院分区:
文献类型:
--
作者:
Kang M;Zhang Z;Xu W;Wen H;Zhu W;Wu Q;Wu H;Gong J;Wang Z;Wang D;Tang BZ
Photodynamic therapy (PDT) has long been recognized to be a promising approach for cancer treatment. However, the high oxygen dependency of conventional PDT dramatically impairs its overall therapeutic efficacy, especially in hypoxic solid tumors. Exploration of distinctive PDT strategy involving both high‐performance less‐oxygen‐dependent photosensitizers (PSs) and prominent drug delivery system is an appealing yet significantly challenging task. Herein, a precise nuclear targeting PDT protocol based on type‐I PSs with aggregation‐induced emission (AIE) characteristics is fabricated for the first time. Of the two synthesized AIE PSs, TTFMN is demonstrated to exhibit superior AIE property and stronger type‐I reactive oxygen species (ROS) generation efficiency owing to the introduction of tetraphenylethylene and smaller singlet–triplet energy gap, respectively. With the aid of a lysosomal acid‐activated TAT‐peptide‐modified amphiphilic polymer poly(lactic acid)12k–poly(ethylene glycol)5k–succinic anhydride‐modified TAT, the corresponding TTFMN‐loaded nanoparticles accompanied with acid‐triggered nuclear targeting peculiarity can quickly accumulate in the tumor site, effectively generate type‐I ROS in the nuclear region and significantly suppress the tumor growth under white light irradiation with minimized systematic toxicity. This delicate “Good Steel Used in the Blade” tactic significantly maximizes the PDT efficacy and offers a conceptual while practical paradigm for optimized cancer treatment in further translational medicine. A precise nuclear targeting photodynamic therapy (PDT) protocol based on tactfully designed type‐I photosensitizers with aggregation‐induced emission characteristics is fabricated for the first time with the aid of a lysosomal acid‐activated TAT‐modified nuclear delivery system, which can significantly maximize the PDT efficacy.
登录
查看更多内容
DOI:
10.3322/caac.20114
发表时间:
2011-07
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Agostinis P;Berg K;Cengel KA;Foster TH;Girotti AW;Gollnick SO;Hahn SM;Hamblin MR;Juzeniene A;Kessel D;Korbelik M;Moan J;Mroz P;Nowis D;Piette J;Wilson BC;Golab J
通讯作者:
Golab J
影响因子:
15
作者:
Jacobs, Aaron C.;Resendiz, Marino J. E.;Greenberg, Marc M.
通讯作者:
Greenberg, Marc M.
影响因子:
4.8
作者:
Garcia-Diaz, Maria;Huang, Ying-Ying;Hamblin, Michael R.
通讯作者:
Hamblin, Michael R.
影响因子:
15
作者:
Chowdhury, Goutam;Junnotula, Venkatraman;Gates, Kent S.
通讯作者:
Gates, Kent S.
影响因子:
254.7
作者:
Jemal, Ahmedin;Siegel, Rebecca;Ward, Elizabeth
通讯作者:
Ward, Elizabeth